NYSE:PVCT

Provectus Pharmaceuticals Stock Forecast

etoro logo Buy PVCT
*Your capital is at risk
$0.0603
-0.0017 (-2.74%)
At Close: Jun 03, 2026
AI Analysis AI Analysis of PVCT AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add PVCT to Watchlist?
  • Easy Tracking In The Watchlist
PDF

High volatility in Provectus Pharmaceuticals, Inc stock price on Wednesday which ended trading at $0.0603
(Updated on Jun 03, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jun 03, 2026

The Provectus Pharmaceuticals, Inc stock price fell by -2.74% on the last day (Wednesday, 3rd Jun 2026) from $0.0620 to $0.0603. During the last trading day the stock fluctuated 21.13% from a day low at $0.0568 to a day high of $0.0688. The price has fallen in 5 of the last 10 days and is down by -8.73% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -137 thousand shares and in total, 88 shares were bought and sold for approximately $5.31 .

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.0572 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 27.25% during the next 3 months and, with a 90% probability hold a price between $0.0728 and $0.0932 at the end of this 3-month period.

PVCT Signals & Forecast

There are few to no technical positive signals at the moment. The Provectus Pharmaceuticals, Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $0.0637 and $0.0611. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, May 14, 2026, and so far it has fallen -13.86%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Provectus Pharmaceuticals, Inc stock

Provectus Pharmaceuticals, Inc finds support from accumulated volume at $0.0600 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0120 between high and low, or 21.13%. For the last week the stock has had daily average volatility of 12.29%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (PVCT) For The Upcoming Trading Day Of Thursday 4th

For the upcoming trading day on Thursday, 4th we expect Provectus Pharmaceuticals, Inc to open at $0.0620, and during the day (based on 14 day Average True Range), to move between $0.0577 and $0.0629, which gives a possible trading interval of +/-$0.0053 (+/-9.12%) up or down from last closing price. If Provectus Pharmaceuticals, Inc takes out the full calculated possible swing range there will be an estimated 9.12% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.0600 (0.50%) than the resistance at $0.0614 (1.82%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Provectus Pharmaceuticals, Inc stock A Buy?

The Provectus Pharmaceuticals, Inc stock holds several negative signals and despite the positive trend, we believe Provectus Pharmaceuticals, Inc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

Current score: -4.108 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 4, 2026 - $0.0620 ( 2.76%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

PVCT Performance

Trading levels for PVCT

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.0740 22.66%
R2 0.0694 15.06%
R1 0.0666 10.37%
Price 0.0603
S1 0.0574 -4.84%
S2 0.0546 -9.53%
S3 0.0500 -17.14%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.0675 11.94%
R2 0.0620 2.82%
R1 0.0614 1.82%
Price 0.0603
S1 0.0600 -0.498%
S2 0.0549 -8.96%
S3 0.0530 -12.11%

FAQ

What is the symbol for Provectus Pharmaceuticals, Inc Stock and on which exchange is it traded?
The symbol for Provectus Pharmaceuticals, Inc is PVCT and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell Provectus Pharmaceuticals, Inc Stock?
The Provectus Pharmaceuticals, Inc stock holds several negative signals and despite the positive trend, we believe Provectus Pharmaceuticals, Inc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

How to buy Provectus Pharmaceuticals, Inc Stock?
Provectus Pharmaceuticals, Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Provectus Pharmaceuticals, Inc Stock.

What's the current price of Provectus Pharmaceuticals, Inc Stock?
As of the end of day on the Jun 03, 2026, the price of an Provectus Pharmaceuticals, Inc (PVCT) share was $0.0603.

What is the 52-week high and low for Provectus Pharmaceuticals, Inc Stock?
The 52-week high for Provectus Pharmaceuticals, Inc Stock is $0.105 and the 52-week low is $0.0380.

What is the market capitalization of Provectus Pharmaceuticals, Inc Stock?
As of the Jun 03, 2026, the market capitalization of Provectus Pharmaceuticals, Inc is 25.343M.
Click to get the best stock tips daily for free!
ABOUT PROVECTUS PHARMACEUTICALS, INC
Provectus Pharmaceuticals
Provectus Biopharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing immunotherapy medicines based on halogenated xanthenes. It develops PV-10, an investigational autolytic cancer immunotherapy for adult solid tumor cancers, such as melanoma and gastrointestinal tumors, including hepatocellular carcinoma; colorectal cancer metastatic to the liver; neuroendocrine tumors metastatic to the liver; uveal melanoma metastati...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE